نتایج جستجو برای: amiodarone

تعداد نتایج: 4417  

Journal: :The Medical journal of Australia 2002
Ian R Gough Jenny Gough

LESSONS FROM PRACTICE AMIODARONE is used in the management of cardiac dysrhythmias. Accumulation of amiodarone in the thyroid gland may result in thyroid dysfunction, either hypothyroidism or thyrotoxicosis.1 Amiodarone-associated thyrotoxicosis (AAT) occurs in about 3% of patients.2 In some patients, cessation of amiodarone is not practical, as it may be the only effective anti-arrhythmic agen...

Journal: :British medical journal 1986
E Monteiro A Galvão-teles M L Santos L Mourão M J Correia J Lopo Tuna C Ribeiro

Changes in thyroid function may occur during treatment with amiodarone. A double blind prospective trial of amiodarone and placebo was performed in 37 patients in the subacute phase of myocardial infarction. Though none of the patients assigned to receive placebo developed any antibody, six of 13 patients treated with amiodarone developed antithyroid microsomal antibodies. There was no differen...

2007
S. D. RAJENDRAN K. P. ARUN

A high performance liquid chromatographic method is described for simultaneous estimation of amiodarone and its metabolite desethylamiodarone in plasma. After precipitation with acetonitrile, the separation of amiodarone, desethylamiodarone and internal standard was accomplished using reversed phase chromatography. The mobile phase, a combination of ammonium acetate (pH 3.5 adjusted with ortho ...

Journal: :Physiological research 2001
S Micuda M Hodac L Sispera P Parízek M Pleskot G Zimova J Cerman J Martínková V Pidrman

The present study was undertaken to evaluate the use of cortisol 6beta-hydroxylation in defining the effect of amiodarone on cytochrome CYP3A activity. To accomplish this goal, the in vivo activity of CYP3A was estimated by measuring the 24-hour urinary excretion of 6beta-hydroxycortisol (6beta-OHC) and by calculating 24-hour ratio of 6beta-hydroxycortisol to urinary free cortisol (6beta-OHC/UF...

Journal: :Journal of managed care pharmacy : JMCP 2006
Courtney L Bickford Anne P Spencer

OBJECTIVE Amiodarone is an effective antiarrhythmic, but the clinical usefulness of this agent is complicated by its extensive side-effect profile, which necessitates careful patient selection and frequent monitoring. The purpose of this study was to quantify adherence to published recommendations for baseline monitoring when initiating inpatient amiodarone therapy at a university teaching hosp...

Journal: :Progress in cardiovascular diseases 1989
A Kadish F Morady

0 VER THE PAST several years oral amiodarone has been shown to be effective for a wide variety of supraventricular and ventricular arrhythmias.‘-” A unique aspect of amiodarone therapy is the long time required to reach maximum efficacy.‘6’* For example, Rakita and Sobol used continuous ambulatory electrocardiographic monitoring to compare several different oral regimens for amiodarone loading ...

Journal: :Circulation 1989
K P Anderson R Walker T Dustman R L Lux P R Ershler R E Kates P M Urie

The electrophysiologic effects of amiodarone were examined in 13 dogs that received 30 g amiodarone orally during 3 weeks and compared with 13 control dogs that did not receive amiodarone. Longitudinal and transverse epicardial conduction velocities were estimated with a square array of 64 closely spaced electrodes and a computer-assisted acquisition and analysis system. Amiodarone caused a rat...

Journal: :Circulation 1993
K Nademanee B N Singh W G Stevenson J N Weiss

Amiodarone is a viable drug for preventing sudden cardiac death, particularly during the first year after MI. If larger trials confirm the aforementioned prospective trials of Ceremuzynski et al, Cairns et al, and the BASIS trial, the efficacy of amiodarone would outweigh the risk of its side effects during the first year after MI. Based on the long-term observation from the BASIS trial, the du...

Journal: :Journal of the American College of Cardiology 1988
I Helmy J M Herre G Gee H Sharkey P Malone M J Sauve J C Griffin M M Scheinman

Efficacy, side effects and predictors of response for intravenous amiodarone were evaluated in 46 patients with recurrent drug-refractory sustained ventricular tachycardia or ventricular fibrillation, or both, who were treated with intravenous amiodarone. Of the 46 patients, 27 (58.5%) responded early to intravenous amiodarone and 6 (13%) showed a late response to amiodarone. The majority of pa...

Journal: :World journal of gastroenterology 2007
Yen-Yuan Chen Ching-Yu Chen Kai-Kuen Leung

Amiodarone, a class III antiarrhythmic drug, is one of the most effective drugs used in the treatment of ventricular and paroxysmal supraventricular tachyarrhythmia. Adverse effects of amiodarone including pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and thyroid diseases are well understood. A 66-year old woman with acute pancreatitis was admitted to our hospital with the comp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید